The First One

The National Center for Advancing Translational Sciences is embarking on its first clinical trial, reports the Nature News Blog. The trial is examining a drug, called DEX-M74, for hereditary inclusion body myopathy, a condition that strikes young adults and for which there is no treatment, a press release adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

An NCATS License

Share It All

To Court

Mitochondrial Trades

And the Result Is…

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.